Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hutterer

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Journal of Endourology|November 29, 2007
External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomyKevin C Zorn, Andrea Gallina, Georg C Hutterer, et al.
Anticancer Research|October 2, 2019
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell TumorsAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
World Journal of Urology|April 6, 2023
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgeryValentina Egger, Georg C Hutterer, Johannes Mischinger, et al.
Antiviral Research|August 13, 2016
The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitorsC Hutterer, S Hamilton, M Steingruber, et al.
European Urology|March 14, 2007
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomyAlberto Briganti, Felix K-H Chun, Georg C Hutterer, et al.
BJU International|May 10, 2007
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancerFelix K-H Chun, Georg C Hutterer, Paul Perrotte, et al.
International Journal of Molecular Sciences|December 6, 2016
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer CellsAnna-Maria Pehserl, Anna Lena Ress, Stefanie Stanzer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal of Endourology|November 29, 2007
External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomyKevin C Zorn, Andrea Gallina, Georg C Hutterer, et al.
Anticancer Research|October 2, 2019
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell TumorsAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
World Journal of Urology|April 6, 2023
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgeryValentina Egger, Georg C Hutterer, Johannes Mischinger, et al.
Antiviral Research|August 13, 2016
The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitorsC Hutterer, S Hamilton, M Steingruber, et al.
European Urology|March 14, 2007
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomyAlberto Briganti, Felix K-H Chun, Georg C Hutterer, et al.
BJU International|May 10, 2007
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancerFelix K-H Chun, Georg C Hutterer, Paul Perrotte, et al.
International Journal of Molecular Sciences|December 6, 2016
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer CellsAnna-Maria Pehserl, Anna Lena Ress, Stefanie Stanzer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Pageof 9